Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Short-term mechanisms influencing volumetric brain dynamics.

Dieleman N, Koek HL, Hendrikse J.

Neuroimage Clin. 2017 Sep 6;16:507-513. doi: 10.1016/j.nicl.2017.09.002. eCollection 2017. Review.

2.

Amyloid precursor protein modulates macrophage phenotype and diet-dependent weight gain.

Puig KL, Brose SA, Zhou X, Sens MA, Combs GF, Jensen MD, Golovko MY, Combs CK.

Sci Rep. 2017 Mar 6;7:43725. doi: 10.1038/srep43725.

3.
4.

Increased GABA concentrations in type 2 diabetes mellitus are related to lower cognitive functioning.

van Bussel FC, Backes WH, Hofman PA, Puts NA, Edden RA, van Boxtel MP, Schram MT, Stehouwer CD, Wildberger JE, Jansen JF.

Medicine (Baltimore). 2016 Sep;95(36):e4803. doi: 10.1097/MD.0000000000004803.

5.

Diabetes and Cognitive Impairment.

Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW.

Curr Diab Rep. 2016 Sep;16(9):87. doi: 10.1007/s11892-016-0775-x. Review.

6.

Higher fasting plasma glucose is associated with striatal and hippocampal shape differences: the 2sweet project.

Zhang T, Shaw M, Humphries J, Sachdev P, Anstey KJ, Cherbuin N.

BMJ Open Diabetes Res Care. 2016 May 26;4(1):e000175. doi: 10.1136/bmjdrc-2015-000175. eCollection 2016.

7.

Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults.

Wennberg AM, Spira AP, Pettigrew C, Soldan A, Zipunnikov V, Rebok GW, Roses AD, Lutz MW, Miller MM, Thambisetty M, Albert MS.

J Neurol Sci. 2016 Jun 15;365:89-95. doi: 10.1016/j.jns.2016.04.017. Epub 2016 Apr 14.

8.

Effects of glucose and insulin on secretion of amyloid-β by human adipose tissue cells.

Tharp WG, Gupta D, Smith J, Jones KP, Jones AM, Pratley RE.

Obesity (Silver Spring). 2016 Jul;24(7):1471-9. doi: 10.1002/oby.21494. Epub 2016 May 13.

9.

Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise.

Suo C, Singh MF, Gates N, Wen W, Sachdev P, Brodaty H, Saigal N, Wilson GC, Meiklejohn J, Singh N, Baune BT, Baker M, Foroughi N, Wang Y, Mavros Y, Lampit A, Leung I, Valenzuela MJ.

Mol Psychiatry. 2016 Nov;21(11):1633-1642. doi: 10.1038/mp.2016.19. Epub 2016 Mar 22.

10.

Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat.

Mangili A, Falutz J, Mamputu JC, Stepanians M, Hayward B.

PLoS One. 2015 Oct 12;10(10):e0140358. doi: 10.1371/journal.pone.0140358. eCollection 2015.

11.

Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 Years.

Luchsinger JA, Cabral R, Eimicke JP, Manly JJ, Teresi J.

Psychosom Med. 2015 Jul-Aug;77(6):653-63. doi: 10.1097/PSY.0000000000000208.

12.

Activation of mTOR: a culprit of Alzheimer's disease?

Cai Z, Chen G, He W, Xiao M, Yan LJ.

Neuropsychiatr Dis Treat. 2015 Apr 9;11:1015-30. doi: 10.2147/NDT.S75717. eCollection 2015. Review.

13.

Insulin resistance is an important risk factor for cognitive impairment in elderly patients with primary hypertension.

Ma L, Feng M, Qian Y, Yang W, Liu J, Han R, Zhu H, Li Y.

Yonsei Med J. 2015 Jan;56(1):89-94. doi: 10.3349/ymj.2015.56.1.89.

14.

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.

Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M.

Parkinsonism Relat Disord. 2014 Dec;20(12):1394-8. doi: 10.1016/j.parkreldis.2014.10.008. Epub 2014 Oct 15.

15.

A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms.

Meusel LA, Kansal N, Tchistiakova E, Yuen W, MacIntosh BJ, Greenwood CE, Anderson ND.

Front Aging Neurosci. 2014 Jul 8;6:148. doi: 10.3389/fnagi.2014.00148. eCollection 2014. Review.

16.

The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control.

West RK, Ravona-Springer R, Schmeidler J, Leroith D, Koifman K, Guerrero-Berroa E, Preiss R, Hoffman H, Silverman JM, Heymann A, Schnaider-Beeri M.

Am J Geriatr Psychiatry. 2014 Oct;22(10):1055-9. doi: 10.1016/j.jagp.2014.01.010. Epub 2014 Jan 23.

17.

Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.

Mielke MM, Vemuri P, Rocca WA.

Clin Epidemiol. 2014 Jan 8;6:37-48. doi: 10.2147/CLEP.S37929. eCollection 2014. Review.

18.

Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease.

Morabito MV, Berman DE, Schneider RT, Zhang Y, Leibel RL, Small SA.

Neurobiol Dis. 2014 May;65:188-92. doi: 10.1016/j.nbd.2013.12.017. Epub 2014 Jan 14.

19.

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Reitz C, Mayeux R.

Biochem Pharmacol. 2014 Apr 15;88(4):640-51. doi: 10.1016/j.bcp.2013.12.024. Epub 2014 Jan 4. Review.

20.

Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease.

Tucsek Z, Toth P, Sosnowska D, Gautam T, Mitschelen M, Koller A, Szalai G, Sonntag WE, Ungvari Z, Csiszar A.

J Gerontol A Biol Sci Med Sci. 2014 Oct;69(10):1212-26. doi: 10.1093/gerona/glt177. Epub 2013 Nov 22.

Supplemental Content

Support Center